The Mechanism of Action and Clinical Transformation Evaluation of Antioxidant Drugs in Cisplatin-Induced Nephrotoxicity
DOI:
https://doi.org/10.54097/n1renk71Keywords:
Cisplatin nephrotoxicity; antioxidant; N-acetylcysteine; oxidative stress; inflammatory.Abstract
In the current clinical practice of cancer, cisplatin has been established as the basic drug of chemotherapy for a variety of solid tumors with its exact efficacy. Although it is widely used, its nephrotoxicity seriously limits application and efficacy. Because oxidative stress is the core cause of cisplatin nephrotoxicity, antioxidant intervention is particularly important for reducing renal injury. In recent years, the protective effect of antioxidants such as N-acetylcysteine (NAC) on cisplatin nephrotoxicity has been confirmed in cell and animal experiments, but there are still many difficulties and challenges in its clinical transformation. This article reviews the core pathological mechanisms of cisplatin nephrotoxicity, including selective accumulation in the kidney, imbalance between oxidative stress and antioxidant defense, inflammatory cascade, and a variety of programmed cell death. On this basis, taking antioxidant NAC as an example, the mechanisms of its renoprotective effects were analyzed, and the current research progress was summarized. This paper provides a theoretical reference for the protective mechanism of antioxidants in cisplatin nephrotoxicity, and suggests the synergistic potential of combination drugs. However, the current research in this field still lacks high-quality standardized dosing regimens and high-quality clinical evidence. Future investigations can consider large-scale sample clinical trials, the establishment of individualized dosing schemes and the development of combination drugs, which can promote the transformation of basic achievements to clinical applications.
Downloads
References
[1] Elmorsy, E. A., Saber, S., Hamad, R. S., Abdel-Reheim, M. A., El-Kott, A. F., AlShehri, M. A., Morsy, K., Salama, S. A., & Youssef, M. E. (2024). Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 203, 106939. https://doi.org/10.1016/j.ejps.2024.106939. DOI: https://doi.org/10.1016/j.ejps.2024.106939
[2] Fang, Cy., Lou, Dy., Zhou, Lq. et al. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 42, 1951–1969 (2021). https://doi.org/10.1038/s41401-021-00620-9 DOI: https://doi.org/10.1038/s41401-021-00620-9
[3] Loren, P., Saavedra, N., Saavedra, K., Zambrano, T., Moriel, P., & Salazar, L. A. (2021). Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update. Pharmaceuticals (Basel, Switzerland), 14(6), 491. https://doi.org/10.3390/ph14060491. DOI: https://doi.org/10.3390/ph14060491
[4] Güntürk, I., Yazici, C., Köse, S. K., Dağli, F., Yücel, B., & Yay, A. H. (2019). The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model. Turkish journal of medical sciences, 49(6), 1789–1799. https://doi.org/10.3906/sag-1903-225. DOI: https://doi.org/10.3906/sag-1903-225
[5] Liu, J., Wang, Y., Qiao, P., Ying, Y., Lin, S., Lu, F., Gao, C., Li, M., Yang, B., & Zhou, H. (2025). Mechanisms of Cisplatin-Induced Acute Kidney Injury: The Role of NRF2 in Mitochondrial Dysfunction and Metabolic Reprogramming. Antioxidants (Basel, Switzerland), 14(7), 775. https://doi.org/10.3390/antiox14070775. DOI: https://doi.org/10.3390/antiox14070775
[6] Zhang, D., Luo, G., Jin, K., Bao, X., Huang, L., & Ke, J. (2023). The underlying mechanisms of cisplatin-induced nephrotoxicity and its therapeutic intervention using natural compounds. Naunyn-Schmiedeberg's archives of pharmacology, 396(11), 2925–2941. https://doi.org/10.1007/s00210-023-02559-6. DOI: https://doi.org/10.1007/s00210-023-02559-6
[7] Prabu, O. G., Islami, N. N., Mellenia, J., Nugroho, P., Rajabto, W., & Shatri, H. (2025). N-Acetylcysteine Role in Maintaining Renal Function in Cancer Patients with Cisplatin-Based Chemotherapy. International journal of nephrology and renovascular disease, 18, 337–348. https://doi.org/10.2147/IJNRD.S563298 DOI: https://doi.org/10.2147/IJNRD.S563298
[8] Zhang, H. N., Xiao, W. Q., Lee, D. H., Li, N., Feng, Y. Y., Su, T., Gu, H. Y., Yoon, I., Jung, H., Lee, K. H., Cho, H. J., Han, Y. H., Sun, H. N., & Kwon, T. (2024). Cisplatin Induces Kidney Cell Death via ROS-dependent MAPK Signaling Pathways by Targeting Peroxiredoxin I and II in African Green Monkey (Chlorocebus aethiops sabaeus) Kidney Cells. In vivo (Athens, Greece), 38(2), 630–639. https://doi.org/10.21873/invivo.13482 DOI: https://doi.org/10.21873/invivo.13482
[9] Badr, A. M., Al-Kharashi, L. A., Attia, H., Alshehri, S., Alajami, H. N., Ali, R. A., & Mahran, Y. F. (2023). TLR4/Inflammasomes Cross-Talk and Pyroptosis Contribute to N-Acetyl Cysteine and Chlorogenic Acid Protection against Cisplatin-Induced Nephrotoxicity. Pharmaceuticals (Basel, Switzerland), 16(3), 337. https://doi.org/10.3390/ph16030337 DOI: https://doi.org/10.3390/ph16030337
[10] Wang, J., Zhao, S., & Ren, B. H. (2020). Protective effect and mechanism analysis of N-acetylcysteine on cisplatin-induced nephrotoxicity. Chinese Journal of Immunology, 36(4), 390–394.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

